VEGFC and neoplasm: Tumour samples of all included 100 patients were analysed for VEGF-A, VEGF-C and VEGF-D expression by Western Blot, including 80 (80%) with ‘extensive intraperitoneal’ tumour growth and 20 patients (20%) with ‘predominant retroperitoneal’ tumour involvement.